• 1
    Chin J. Control of Communicable Diseases Manual. Washington: American Public Health Association, 2000.
  • 2
    Arden NH. Control of influenza in the long-term-care facility: a review of established approaches and newer options. Infect Control Hosp Epidemiol 2000; 21:5964.
  • 3
    Loeb M, McGeer A, McArthur M, Peeling RW, Petric M, Simor AE. Surveillance for outbreaks of respiratory tract infections in nursing homes. CMAJ 2000; 162:11331137.
  • 4
    Coles FB, Balzano GJ, Morse DL. An outbreak of influenza A (H3N2) in a well immunized nursing home population. J Am Geriatr Soc 1992; 40:589592.
  • 5
    Gravenstein S, Davidson HE. Current strategies for management of influenza in the elderly population. Clin Infect Dis 2002; 35:729737.
  • 6
    Zadeh MM, Buxton Bridges C, Thompson WW, Arden NH, Fukuda K. Influenza outbreak detection and control measures in nursing homes in the United States. J Am Geriatr Soc 2000; 48:13101315.
  • 7
    Wutzler P, Vogel G. Neuraminidase inhibitors in the treatment of influenza A and B – overview and case reports. Infection 2000; 28:261266.
  • 8
    Peters PH Jr, Gravenstein S, Norwood P et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001; 49:10251031.
  • 9
    Guy RJ, Di Natale R, Kelly HA et al. Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapy. Med J Aust 2004; 180:640642.
  • 10
    Parker R, Loewen N, Skowronski D. Experience with oseltamivir in the control of a nursing home influenza B outbreak. Can Commun Dis Rep 2001; 27:3740.
  • 11
    Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000; 355:827835.
  • 12
    Hayden FG, Atmar RL, Schilling M et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999; 341:13361343.
  • 13
    Hayden FG, Treanor JJ, Fritz RS et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999; 282:12401246.
  • 14
    Bush KA, McAnulty J, McPhie K et al. Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility. Commun Dis Intell 2004; 28:396400.
  • 15
    Playford EG, Dwyer DE. Laboratory diagnosis of influenza virus infection. Pathology 2002; 34:115125.
  • 16
    Australian Government and Department of Health and Welfare. Composition of Australia influenza vaccine for the 2005 season. Commun Dis Intell 2005; 28:396400.
  • 17
    Fiore AE, Shay DK, Broder K et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008; 57: 160.
  • 18
    Rubin MS, Nivin B, Ackelsberg J. Effect of timing of amantadine chemoprophylaxis on severity of outbreaks of influenza a in adult long-term care facilities. Clin Infect Dis 2008; 47:4752.
  • 19
    Gravenstein S. Initiating influenza chemoprophylaxis with the first influenza case: a new institutional standard? Clin Infect Dis 2008; 47:5355.
  • 20
    Aoki FY, Macleod MD, Paggiaro P et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003; 51:123129.
  • 21
    Bowles SK, Lee W, Simor AE et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999–2000. J Am Geriatr Soc 2002; 50:608616.
  • 22
    National Health & Medical Research Council. Influenza; in JelfsJ MacartneyK (ed): The Australian Immunisation Handbook. Canberra: National Capital Printing, 2003.
  • 23
    Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123:518527.
  • 24
    Simonsen L, Viboud C, Taylor R. Influenza vaccination in elderly people. Lancet 2005; 366:2086.
  • 25
    Burls A, Jordan R, Barton P et al. Vaccinating healthcare workers against influenza to protect the vulnerable – is it a good use of healthcare resources?: a systematic review of the evidence and an economic evaluation. Vaccine 2006; 24:42124221.
  • 26
    Van Den Hoven MA, Verweij MF. Should we promote influenza vaccination of health care workers in nursing homes? Some ethical arguments in favour of immunization Age Ageing 2003; 32:487489.
  • 27
    Wilde JA, McMillan JA, Serwint J, Butta J, O’Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999; 281:908913.
  • 28
    Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol 2004; 25:923928.
  • 29
    Potter J, Stott DJ, Roberts MA et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997; 175:16.
  • 30
    Thomas Y, Kaiser L, Wunderli W; EISS Task Group on Near Patient Test . The use of near patient tests in influenza surveillance: Swiss experience and EISS recommendations. Euro Surveill 2003; 8:240246.
  • 31
    Agoritsas K, Mack K, Bonsu BK, Goodman D, Salamon D, Marcon MJ. Evaluation of the Quidel QuickVue test for detection of influenza A and B viruses in the pediatric emergency medicine setting by use of three specimen collection methods. J Clin Microbiol 2006; 44:26382641.
  • 32
    Alexander R, Hurt AC, Lamb D, Wong FY, Hampson AW, Barr IG. A comparison of a rapid test for influenza with laboratory-based diagnosis in a paediatric population. Clin Infect Dis 2005; 29:272276.
  • 33
    Bellei N, Benfica D, Perosa AH, Carlucci R, Barros M, Granato C. Evaluation of a rapid test (QuickVue) compared with the shell vial assay for detection of influenza virus clearance after antiviral treatment. J Virol Methods 2003; 109:8588.
  • 34
    Drinka PJ. Influenza vaccination and antiviral therapy: is there a role for concurrent administration in the institutionalised elderly? Drugs Aging 2003; 20:165174.
  • 35
    Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003; 326:1235.